patent/CN-106456576-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106456576-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e9a9da43f753f517ac1803fd03443f0
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-22
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate	2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c00cc4bdf5c07e0aa8531e7e1c7f5ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d673c24cf09a916aceafcff70e0a5b
publicationDate	2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-106456576-A
titleOfInvention	Methods of treating advanced nonalcoholic steatohepatitis
abstract	The compound of formula (I), or the metabolite of the compound of formula (I), or the ester of the compound of formula (I), or the metabolite of the ester of the compound of formula (I), or their respective pharmaceutically acceptable salts are used to inhibit Or the treatment of advanced non-alcoholic steatohepatitis, the disorders causing it or caused by it, and/or their respective side effects, wherein m, n , X1 and X2 are as defined herein.
priorityDate	2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013158123-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467492710

Total number of triples: 31.